Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03503409
Title IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Groupe Francophone des Myelodysplasies
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Ivosidenib

Age Groups: senior | adult
Covered Countries ITA | FRA

Additional content available in CKB BOOST